KUALA LUMPUR, Feb 28 — Malaysia’s medical devices industry registered approved investments totalling RM807.6 million for the first nine months of 2023 (9M 2023), said the Malaysian Investment Development Authority.

KUALA LUMPUR, Jan 26 — Duopharma (M) Sendirian Bhd (DMSB), a wholly-owned subsidiary of Duopharma Biotech Berhad will procure and supply 6.4 million doses of Russian developed Covid-19 vaccine, “Sputnik V” in Malaysia.